TY - JOUR
T1 - The role of catecholamines in the pathogenesis of neurogenic pulmonary edema associated with subarachnoid hemorrhage
AU - Inamasu, Joji
AU - Sugimoto, Keiko
AU - Yamada, Yasuhiro
AU - Ganaha, Tsukasa
AU - Ito, Keisuke
AU - Watabe, Takeya
AU - Hayashi, Takuro
AU - Kato, Yoko
AU - Ozaki, Yukio
AU - Hirose, Yuichi
PY - 2012/12
Y1 - 2012/12
N2 - Background Neurogenic pulmonary edema (NPE) occurs frequently after aneurysmal subarachnoid hemorrhage (SAH), and excessive release of catecholamines (epinephrine/ norepinephrine) has been suggested as its principal cause. The objective of this retrospective study is to evaluate the relative contribution of each catecholamine in the pathogenesis of NPE associated with SAH. Methods Records of 63 SAH patients (20 men/43 women) whose plasma catecholamine levels were measured within 48 h of SAH onset were reviewed, and the clinical characteristics and laboratory data of those who developed earlyonset NPE were analyzed thoroughly. Results Seven patients (11 %) were diagnosed with NPE on admission. Demographic comparison revealed that the NPE + group sustained more severe SAH than the NPE- group. Cardiac dysfunction was also significantly more profound in the former, and the great majority of the NPE+ group sustained concomitant cardiac wall motion abnormality. There was no significant difference in the plasma epinephrine levels between NPE+ and NPE- group (324.6±172.8 vs 163.1±257.2 pg/ml, p00.11). By contrast, plasma norepinephrine levels were significantly higher in the NPE+ group (2977.6±2034.5 vs 847.9±535.6 pg/ml, p<0.001). Multivariate regression analysis revealed that increased norepinephrine levels were associated with NPE (OR, 1.003; 95 % CI, 1.002-1.007). Plasma epinephrine and norepinephrine levels were positively correlated (R00.48, p< 0.001). According to receiver operating characteristic curve analysis, the threshold value for plasma norepinephrine predictive of NPE was 2,000 pg/ml, with an area under the curve value of 0.85. Conclusions Elevated plasma norepinephrine may have more active role in the pathogenesis of SAH-induced NPE compared with epinephrine, although both catecholamines may be involved via multiple signaling pathways.
AB - Background Neurogenic pulmonary edema (NPE) occurs frequently after aneurysmal subarachnoid hemorrhage (SAH), and excessive release of catecholamines (epinephrine/ norepinephrine) has been suggested as its principal cause. The objective of this retrospective study is to evaluate the relative contribution of each catecholamine in the pathogenesis of NPE associated with SAH. Methods Records of 63 SAH patients (20 men/43 women) whose plasma catecholamine levels were measured within 48 h of SAH onset were reviewed, and the clinical characteristics and laboratory data of those who developed earlyonset NPE were analyzed thoroughly. Results Seven patients (11 %) were diagnosed with NPE on admission. Demographic comparison revealed that the NPE + group sustained more severe SAH than the NPE- group. Cardiac dysfunction was also significantly more profound in the former, and the great majority of the NPE+ group sustained concomitant cardiac wall motion abnormality. There was no significant difference in the plasma epinephrine levels between NPE+ and NPE- group (324.6±172.8 vs 163.1±257.2 pg/ml, p00.11). By contrast, plasma norepinephrine levels were significantly higher in the NPE+ group (2977.6±2034.5 vs 847.9±535.6 pg/ml, p<0.001). Multivariate regression analysis revealed that increased norepinephrine levels were associated with NPE (OR, 1.003; 95 % CI, 1.002-1.007). Plasma epinephrine and norepinephrine levels were positively correlated (R00.48, p< 0.001). According to receiver operating characteristic curve analysis, the threshold value for plasma norepinephrine predictive of NPE was 2,000 pg/ml, with an area under the curve value of 0.85. Conclusions Elevated plasma norepinephrine may have more active role in the pathogenesis of SAH-induced NPE compared with epinephrine, although both catecholamines may be involved via multiple signaling pathways.
UR - http://www.scopus.com/inward/record.url?scp=84871080689&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84871080689&partnerID=8YFLogxK
U2 - 10.1007/s00701-012-1515-x
DO - 10.1007/s00701-012-1515-x
M3 - Review article
C2 - 23053288
AN - SCOPUS:84871080689
SN - 0001-6268
VL - 154
SP - 2179
EP - 2184
JO - Acta Neurochirurgica
JF - Acta Neurochirurgica
IS - 12
ER -